225 related articles for article (PubMed ID: 35037658)
1. Culture of Bladder Cancer Organoids as Precision Medicine Tools.
Thomas PB; Perera MPJ; Alinezhad S; Joshi A; Saadat P; Nicholls C; Devonport CP; Calabrese AR; Templeton AR; Wood JR; Mackenzie NJ; Jeffery PL; Vela I; Williams ED
J Vis Exp; 2021 Dec; (178):. PubMed ID: 35037658
[TBL] [Abstract][Full Text] [Related]
2. Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine.
Pamarthy S; Sabaawy HE
Mol Cancer; 2021 Sep; 20(1):125. PubMed ID: 34587953
[TBL] [Abstract][Full Text] [Related]
3. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.
Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J
Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine.
Taverna JA; Hung CN; Williams M; Williams R; Chen M; Kamali S; Sambandam V; Hsiang-Ling Chiu C; Osmulski PA; Gaczynska ME; DeArmond DT; Gaspard C; Mancini M; Kusi M; Pandya AN; Song L; Jin L; Schiavini P; Chen CL
Lung Cancer; 2024 Apr; 190():107533. PubMed ID: 38520909
[TBL] [Abstract][Full Text] [Related]
5. The potential of organoids in urological cancer research.
Wang S; Gao D; Chen Y
Nat Rev Urol; 2017 Jul; 14(7):401-414. PubMed ID: 28534535
[TBL] [Abstract][Full Text] [Related]
6. Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer.
Cartry J; Bedja S; Boilève A; Mathieu JRR; Gontran E; Annereau M; Job B; Mouawia A; Mathias P; De Baère T; Italiano A; Besse B; Sourrouille I; Gelli M; Bani MA; Dartigues P; Hollebecque A; Smolenschi C; Ducreux M; Malka D; Jaulin F
J Exp Clin Cancer Res; 2023 Oct; 42(1):281. PubMed ID: 37880806
[TBL] [Abstract][Full Text] [Related]
7. Mouse and human urothelial cancer organoids: A tool for bladder cancer research.
Mullenders J; de Jongh E; Brousali A; Roosen M; Blom JPA; Begthel H; Korving J; Jonges T; Kranenburg O; Meijer R; Clevers HC
Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4567-4574. PubMed ID: 30787188
[TBL] [Abstract][Full Text] [Related]
8. Establishment of 2.5D organoid culture model using 3D bladder cancer organoid culture.
Abugomaa A; Elbadawy M; Yamanaka M; Goto Y; Hayashi K; Mori T; Uchide T; Azakami D; Fukushima R; Yoshida T; Shibutani M; Yamashita R; Kobayashi M; Yamawaki H; Shinohara Y; Kaneda M; Usui T; Sasaki K
Sci Rep; 2020 Jun; 10(1):9393. PubMed ID: 32523078
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture.
Elbadawy M; Usui T; Mori T; Tsunedomi R; Hazama S; Nabeta R; Uchide T; Fukushima R; Yoshida T; Shibutani M; Tanaka T; Masuda S; Okada R; Ichikawa R; Omatsu T; Mizutani T; Katayama Y; Noguchi S; Iwai S; Nakagawa T; Shinohara Y; Kaneda M; Yamawaki H; Sasaki K
Cancer Sci; 2019 Sep; 110(9):2806-2821. PubMed ID: 31254429
[TBL] [Abstract][Full Text] [Related]
10. Advantages and limitations of 3D organoids and ex vivo tumor tissue culture in personalized medicine for prostate cancer.
Mickova A; Morong M; Levková M; Kurfúrstová D; Kharaishvili G; Überall I; Student V; Student V; Drapela S; Soucek K; Bouchal J
Klin Onkol; 2022; 35(6):473-481. PubMed ID: 36513514
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.
Praharaj PP; Bhutia SK; Nagrath S; Bitting RL; Deep G
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):117-127. PubMed ID: 29360544
[TBL] [Abstract][Full Text] [Related]
12. Urinary Tract Tumor Organoids Reveal Eminent Differences in Drug Sensitivities When Compared to 2-Dimensional Culture Systems.
Wei Y; Amend B; Todenhöfer T; Lipke N; Aicher WK; Fend F; Stenzl A; Harland N
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682984
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response.
Frappart PO; Walter K; Gout J; Beutel AK; Morawe M; Arnold F; Breunig M; Barth TF; Marienfeld R; Schulte L; Ettrich T; Hackert T; Svinarenko M; Rösler R; Wiese S; Wiese H; Perkhofer L; Müller M; Lechel A; Sainz B; Hermann PC; Seufferlein T; Kleger A
United European Gastroenterol J; 2020 Jun; 8(5):594-606. PubMed ID: 32213029
[TBL] [Abstract][Full Text] [Related]
14. The OVAREX study: Establishment of ex vivo ovarian cancer models to validate innovative therapies and to identify predictive biomarkers.
Thorel L; Divoux J; Lequesne J; Babin G; Morice PM; Florent R; Desmartin G; Lecouflet L; Marde Alagama C; Leconte A; Clarisse B; Briand M; Rouzier R; Gaichies L; Martin-Françoise S; Le Brun JF; Denoyelle C; Vigneron N; Jeanne C; Blanc-Fournier C; Leman R; Vaur D; Figeac M; Meryet-Figuiere M; Joly F; Weiswald LB; Poulain L; Dolivet E
BMC Cancer; 2024 Jun; 24(1):701. PubMed ID: 38849726
[TBL] [Abstract][Full Text] [Related]
15. Genomic characteristics and drug screening among organoids derived from non-small cell lung cancer patients.
Chen JH; Chu XP; Zhang JT; Nie Q; Tang WF; Su J; Yan HH; Zheng HP; Chen ZX; Chen X; Song MM; Yi X; Li PS; Guan YF; Li G; Deng CX; Rosell R; Wu YL; Zhong WZ
Thorac Cancer; 2020 Aug; 11(8):2279-2290. PubMed ID: 32633046
[TBL] [Abstract][Full Text] [Related]
16. Culture, Manipulation, and Orthotopic Transplantation of Mouse Bladder Tumor Organoids.
Kim Y; Lee J; Kim S; Shin K
J Vis Exp; 2020 Jan; (155):. PubMed ID: 32065155
[TBL] [Abstract][Full Text] [Related]
17. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity.
Tanaka N; Osman AA; Takahashi Y; Lindemann A; Patel AA; Zhao M; Takahashi H; Myers JN
Oral Oncol; 2018 Dec; 87():49-57. PubMed ID: 30527243
[TBL] [Abstract][Full Text] [Related]
18. Development of a system combining comprehensive genotyping and organoid cultures for identifying and testing genotype-oriented personalised medicine for pancreatobiliary cancers.
Shiihara M; Ishikawa T; Saiki Y; Omori Y; Hirose K; Fukushige S; Ikari N; Higuchi R; Yamamoto M; Morikawa T; Nakagawa K; Hayashi H; Mizuma M; Ohtsuka H; Motoi F; Unno M; Okamura Y; Kinoshita K; Furukawa T
Eur J Cancer; 2021 May; 148():239-250. PubMed ID: 33752134
[TBL] [Abstract][Full Text] [Related]
19. Organoid technology in cancer precision medicine.
Xia X; Li F; He J; Aji R; Gao D
Cancer Lett; 2019 Aug; 457():20-27. PubMed ID: 31078736
[TBL] [Abstract][Full Text] [Related]
20. Organoid model of urothelial cancer: establishment and applications for bladder cancer research.
Whyard T; Liu J; Darras FS; Waltzer WC; Romanov V
Biotechniques; 2020 Sep; 69(3):193-199. PubMed ID: 32654505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
